Your browser doesn't support javascript.
loading
Brief Consent Methods Enable Rapid Enrollment in Acute Stroke Trial: Results From the TICH-2 Randomized Controlled Trial.
Law, Zhe Kang; Appleton, Jason P; Scutt, Polly; Roberts, Ian; Al-Shahi Salman, Rustam; England, Timothy J; Werring, David J; Robinson, Thompson; Krishnan, Kailash; Dineen, Robert A; Laska, Ann Charlotte; Lyrer, Philippe A; Egea-Guerrero, Juan Jose; Karlinski, Michal; Christensen, Hanne; Roffe, Christine; Bereczki, Daniel; Ozturk, Serefnur; Thanabalan, Jegan; Collins, Ronan; Beridze, Maia; Ciccone, Alfonso; Duley, Lelia; Shone, Angela; Bath, Philip M; Sprigg, Nikola.
Afiliação
  • Law ZK; Stroke Trials Unit (Z.K.L., J.P.A., P.S., P.M.B., N.S.), University of Nottingham, United Kingdom.
  • Appleton JP; Department of Medicine (Z.K.L.), National University of Malaysia.
  • Scutt P; Stroke Trials Unit (Z.K.L., J.P.A., P.S., P.M.B., N.S.), University of Nottingham, United Kingdom.
  • Roberts I; Stroke, University Hospitals Birmingham NHS Foundation Trust, United Kingdom (J.P.A.).
  • Al-Shahi Salman R; Stroke Trials Unit (Z.K.L., J.P.A., P.S., P.M.B., N.S.), University of Nottingham, United Kingdom.
  • England TJ; Clinical Trials Unit, London School of Hygiene and Tropical Medicine, United Kingdom (I.R.).
  • Werring DJ; Centre for Clinical Brain Sciences, University of Edinburgh, United Kingdom (R.A.-S.S.).
  • Robinson T; Vascular Medicine, Division of Medical Sciences and GEM, Royal Derby Hospital Centre (T.J.E.), University of Nottingham, United Kingdom.
  • Krishnan K; Stroke Research Centre, UCL Queen Square Institute of Neurology, London, United Kingdom (D.J.W.).
  • Dineen RA; Department of Cardiovascular Sciences and NIHR Biomedical Research Centre, University of Leicester, United Kingdom (T.R.).
  • Laska AC; Stroke, Nottingham University Hospitals NHS Trust, United Kingdom (K.K., P.M.B., N.S.).
  • Lyrer PA; Radiological Sciences (R.A.D.), University of Nottingham, United Kingdom.
  • Egea-Guerrero JJ; NIHR Nottingham Biomedical Research Centre, United Kingdom (R.A.D.).
  • Karlinski M; Department of Clinical Sciences, Karolinska Institute Danderyd Hospital, Sweden (A.C.L.).
  • Christensen H; Department of Neurology and Stroke Center, University Hospital Basel and University of Basel, Switzerland (P.A.L.).
  • Roffe C; NeuroCritical Care Unit, Virgen del Rocio University Hospital, Seville, Spain (J.J.E.-G.).
  • Bereczki D; Institute of Psychiatry and Neurology, Warsaw, Poland (M.K.).
  • Ozturk S; Department of Neurology, Bispebjerg Hospital and University of Copenhagen, Denmark (H.C.).
  • Thanabalan J; Stroke Research, School of Medicine, Keele University, Newcastle-Under-Lyme, United Kingdom (C.R.).
  • Collins R; Department of Neurology, Semmelweis University, Budapest, Hungary (D.B.).
  • Beridze M; Selcuk University Faculty of Medicine, Department of Neurology, Konya, Turkey (S.O.).
  • Ciccone A; Department of Surgery, Division of Neurosurgery (J.T.), National University of Malaysia.
  • Duley L; Age Related Health Care/Stroke-Service, Tallaght University Hospital, Dublin, Republic of Ireland (R.C.).
  • Shone A; The First University Clinic of Tbilisi State Medical University, GA (M.B.).
  • Bath PM; Neurology and Stroke Unit, Poma Hospital, ASST di Mantova, Mantua, Italy (A.C.).
  • Sprigg N; Nottingham Clinical Trials Unit (L.D.), University of Nottingham, United Kingdom.
Stroke ; 53(4): 1141-1148, 2022 04.
Article em En | MEDLINE | ID: mdl-34847710
BACKGROUND: Seeking consent rapidly in acute stroke trials is crucial as interventions are time sensitive. We explored the association between consent pathways and time to enrollment in the TICH-2 (Tranexamic Acid in Intracerebral Haemorrhage-2) randomized controlled trial. METHODS: Consent was provided by patients or by a relative or an independent doctor in incapacitated patients, using a 1-stage (full written consent) or 2-stage (initial brief consent followed by full written consent post-randomization) approach. The computed tomography-to-randomization time according to consent pathways was compared using the Kruskal-Wallis test. Multivariable logistic regression was performed to identify variables associated with onset-to-randomization time of ≤3 hours. RESULTS: Of 2325 patients, 817 (35%) gave self-consent using 1-stage (557; 68%) or 2-stage consent (260; 32%). For 1507 (65%), consent was provided by a relative (1 stage, 996 [66%]; 2 stage, 323 [21%]) or a doctor (all 2-stage, 188 [12%]). One patient did not record prerandomization consent, with written consent obtained subsequently. The median (interquartile range) computed tomography-to-randomization time was 55 (38-93) minutes for doctor consent, 55 (37-95) minutes for 2-stage patient, 69 (43-110) minutes for 2-stage relative, 75 (48-124) minutes for 1-stage patient, and 90 (56-155) minutes for 1-stage relative consents (P<0.001). Two-stage consent was associated with onset-to-randomization time of ≤3 hours compared with 1-stage consent (adjusted odds ratio, 1.9 [95% CI, 1.5-2.4]). Doctor consent increased the odds (adjusted odds ratio, 2.3 [1.5-3.5]) while relative consent reduced the odds of randomization ≤3 hours (adjusted odds ratio, 0.10 [0.03-0.34]) compared with patient consent. Only 2 of 771 patients (0.3%) in the 2-stage pathways withdrew consent when full consent was sought later. Two-stage consent process did not result in higher withdrawal rates or loss to follow-up. CONCLUSIONS: The use of initial brief consent was associated with shorter times to enrollment, while maintaining good participant retention. Seeking written consent from relatives was associated with significant delays. REGISTRATION: URL: https://www.isrctn.com; Unique identifier: ISRCTN93732214.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Ácido Tranexâmico / Acidente Vascular Cerebral Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Stroke Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Ácido Tranexâmico / Acidente Vascular Cerebral Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Stroke Ano de publicação: 2022 Tipo de documento: Article